Vancomycin, Daptomycin, Antistaphylococcal β-Lactam, and Trimethoprim-Sulfamethoxazole Monotherapy and Combination Therapy in the Management of Methicillin-Resistant Staphylococcus aureus: A Network Meta-Analysis

Vancomycin, Daptomycin, Antistaphylococcal β-Lactam, and Trimethoprim-Sulfamethoxazole Monotherapy and Combination Therapy in the Management of Methicillin-Resistant Staphylococcus aureus: A Network Meta-Analysis

Objective: The aim was to evaluate the efficacy and safety of vancomycin or daptomycin (VAN/DAP), antistaphylococcal β-lactam (ASBL), trimethoprim-sulfamethoxazole (TMP-SMX), and combination therapy of VAN/DAP + ASBL in the management of methicillin-resistant Staphylococcus aureus (MRSA).Methods: Da...

Full description

Bibliographic Details
Main Authors: Xiaonan Xu, Ni Lu, Pan Song, Mingzhen Zhou, Yuanxiao Li, Zirui Wang, Xin Gao
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Pharmacology
Subjects:
vancomycin
daptomycin
β-lactams
network meta-analysis
MRSA
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.805966/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.805966/full

Similar Items